Şunu mu demek istediniz:
harm » arm (Aramayı Genişlet), farm (Aramayı Genişlet), hard (Aramayı Genişlet)
revolves. » evolves. (Aramayı Genişlet), resolves. (Aramayı Genişlet), evolved. (Aramayı Genişlet)
harm » arm (Aramayı Genişlet), farm (Aramayı Genişlet), hard (Aramayı Genişlet)
revolves. » evolves. (Aramayı Genişlet), resolves. (Aramayı Genişlet), evolved. (Aramayı Genişlet)
-
361
PA ameliorates the reduced developmental competence of MGO-challenged DOs.
Baskı/Yayın Bilgisi 2025Konular: -
362
-
363
The optimal concentration of PA modulates the redox state in COCs challenged with MGO during IVM.
Baskı/Yayın Bilgisi 2025Konular: -
364
Retrospective harm benefit analysis of pre-clinical animal research for six treatment interventions
Baskı/Yayın Bilgisi 2018“…The HBA involves weighing the anticipated benefits of animal research against its predicted harms to animals but there are doubts about how objective and accountable this process is.…”
-
365
-
366
-
367
-
368
-
369
-
370
-
371
-
372
-
373
-
374
Quantification of Diaphragm Mechanics in Pompe Disease Using Dynamic 3D MRI
Baskı/Yayın Bilgisi 2016 -
375
Number of times element is mentioned in panelists’ top three most harmful elements by level.
Baskı/Yayın Bilgisi 2024 -
376
Impact of switching from cigarette smoking to tobacco heating system use on biomarkers of potential harm in a randomized trial
Baskı/Yayın Bilgisi 2024“…We longitudinally assessed biomarkers of potential harm (BoPHs) known to be reversible upon smoking cessation as indicators of pathways involved in the pathogenesis of cardiovascular or respiratory diseases and carcinogenicity. …”
-
377
Binding of 1-NPN and pheromone and analogues to <i>Harm</i>OBP7 and its mutants.
Baskı/Yayın Bilgisi 2013“…Both <i>Harm</i>OBP7-m1 and <i>Harm</i>OBP7-m2 bind all the compounds with lower affinity with respect to the wild type, indicating that the C-terminus, specifically Lys123, is involved in binding these ligands. …”
-
378
-
379
-
380